Earnings History Data for Pyxis Oncology, Inc. (PYXS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Pyxis Oncology, Inc.
Pyxis Oncology Inc. is a preclinical oncology company. It focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers. The company's product pipeline includes antibody drug conjugate and monoclonal antibody. Pyxis Oncology Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-08-2024 | PM | PYXS | Pyxis Oncology | 198.00 | -0.29 | -0.33 | 0.00 | Pyxis Oncology GAAP EPS of -$0.29 [8/15/2024 7:26 AM] |
3.42 | 0.06 (1.79%) |
3.27 | -0.09 (-2.68%) |
1.35 - 6.85 | 934,983 | 420,000 | 3,720 | ||
| 14-05-2024 | PM | PYXS | Pyxis Oncology | 256.00 | -0.06 | -0.27 | 0.00 | Pyxis Oncology GAAP EPS of -$0.06, revenue of $16.1M [5/14/2024 9:09 AM] |
4.20 | -0.09 (-2.10%) |
4.10 | -0.19 (-4.43%) |
1.35 - 6.85 | 508,830 | 420,000 | 20,492 | ||
| 21-03-2024 | PM | PYXS | Pyxis Oncology | 228.00 | -0.33 | -0.49 | 0.00 | Pyxis Oncology GAAP EPS of -$1.85 beats by $0.10 [3/21/2024 11:32 AM] |
4.98 | -0.45 (-8.29%) |
5.00 | -0.43 (-7.92%) |
1.35 - 6.92 | 2,439,035 | 660,000 | 57,917 | ||
| 11-08-2023 | PM | PYXS | Pyxis Oncology | 93.00 | -0.41 | -0.66 | 0.00 | Pyxis Oncology GAAP EPS of -$0.41 [8/11/2023 10:25 AM] |
2.57 | 0.15 (6.20%) |
0.0 | 0.0 (0.00%) |
1.10 - 6.92 | 294,325 | 170,000 | 0 | ||
| 11-05-2023 | PM | PYXS | Pyxis Oncology | 104.00 | -0.54 | -0.84 | 0.00 | Pyxis Oncology GAAP EPS of -$0.54 beats by $0.39 [5/11/2023 10:02 AM] |
3.04 | 0.06 (2.18%) |
2.98 | 0.0 (0.00%) |
1.10 - 6.92 | 666,579 | 470,000 | 2,296 | ||
| 22-03-2023 | PM | PYXS | Pyxis Oncology | 83.00 | -1.04 | -0.85 | 0.00 | Pyxis Oncology GAAP EPS of -$3.65 beats by $0.08 [3/22/2023 8:08 AM] |
2.18 | -0.02 (-0.91%) |
2.27 | 0.07 (3.18%) |
1.10 - 5.31 | 961,245 | 150,000 | 391,035 | ||
| 01-11-2022 | PM | PYXS | Pyxis Oncology | 62.00 | -0.85 | -0.76 | 0.00 | Pyxis Oncology GAAP EPS of -$0.85 misses by $0.03 [11/1/2022 8:04 AM] |
1.71 | -0.16 (-8.82%) |
0.0 | 0.0 (0.00%) |
1.49 - 14.00 | 96,030 | 70,000 | 0 | ||
| 13-05-2022 | PM | PYXS | Pyxis Oncology | 70.00 | -0.97 | -0.62 | 0.00 | 2.10 | -0.11 (-5.18%) |
2.22 | 0.0 (0.00%) |
2.00 - 19.00 | 479,033 | 260,000 | 455 | |||
| 29-03-2022 | PM | PYXS | Pyxis Oncology, Inc. | 154.97 | N/A | -0.34 | 0.00 | Pyxis Oncology GAAP EPS of -$8.95 misses by $5.88 [3/29/2022 7:12 AM] |
4.85 | 0.0 (0.00%) |
4.75 | 0.05 (1.06%) |
4.13 - 19.00 | 282,114 | 80,000 | 731 | ||
|
||||||||||||||||||